Search - tctmd.com

Displaying 1 - 20 of 36

Sort: Relevancy | Date

News Daily News

Combo of Intravascular Imaging and Physiology for PCI Gains Steam in the US

Caitlin E. Cox

January 23, 2026

News Conference News TCT 2025

Sirolimus-Coated Balloon Meets Mark in De Novo Lesions and ISR: SELUTION

Michael O'Riordan

October 26, 2025

News Conference News ACC 2024

IVUS Benefits Patients Receiving DCBs for Fem-Pop Disease

Caitlin E. Cox

April 10, 2024

News Conference News TCT 2023

OCT, IVUS Both Seem to Be Good Options for Complex Coronary Lesions

Todd Neale

October 23, 2023

News Conference News ESC 2023

Four Intravascular Imaging Studies Shared the ESC Spotlight, Yet Shadows Persist

Shelley Wood

August 27, 2023

News Conference News ACC 2023

No Downside to Immediate Complete Revascularization in ACS: BIOVASC

Michael O'Riordan

March 06, 2023

News Conference News ACC 2023

Stable CAD Plaque Morphology Improved by PCSK9 Inhibitors: YELLOW III

Shelley Wood

March 04, 2023

News Daily News

Cardiac Imaging’s Carbon Footprint: Time for Awareness and Action

Yael L. Maxwell

December 16, 2022

News Opinion CV Team Dispatch

July 2022 News Roundup

L.A. McKeown

July 01, 2022

News Opinion CV Team Dispatch

January 2022 News Roundup

L.A. McKeown

January 01, 2022

News Daily News

IVUS-Guided PCI Tied to Better Long-term Outcomes After Acute MI

Todd Neale

October 29, 2021

News Daily News

Primary PCI Underused but Just as Effective in Cancer Patients With STEMI

Michael O'Riordan

February 04, 2021

News Conference News EuroPCR 2019

New Expert Advice on Intracoronary Imaging Urges Shift to Preprocedural Planning

Shelley Wood

May 22, 2019

News Conference News EuroPCR 2019

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

Shelley Wood

May 16, 2019

News Features

Twitter Takes on the Times of India, but the Question Persists: Is Foregoing a Stent an Option?

Shelley Wood

April 30, 2019

News Conference News ACC 2019

High Rate of Residual Ischemia After PCI Despite Excellent Angiographic Outcomes: DEFINE-PCI

Michael O'Riordan

March 21, 2019

News Daily News

ABSORB II Substudy Digs Into Long-term Arterial Remodeling Following BRS, DES Implantation

Yael L. Maxwell

June 29, 2017

News Conference News AHA 2016

PCSK9 Inhibition and Other New Therapies for Lipid Modification: Good News and Bad

Michael O'Riordan

November 15, 2016

News Daily News

MILANO-PILOT Falters, Effectively Ending the ApoA-1 Milano Saga

Michael O'Riordan

November 09, 2016

News Conference News TCT 2016

‘Worrisome’ 3-Year Data From ABSORB II Raise Concerns About First-Generation Bioresorbable Stent

Michael O'Riordan

October 30, 2016

Advertisement

Combo of Intravascular Imaging and Physiology for PCI Gains Steam in the US

Sirolimus-Coated Balloon Meets Mark in De Novo Lesions and ISR: SELUTION

IVUS Benefits Patients Receiving DCBs for Fem-Pop Disease

OCT, IVUS Both Seem to Be Good Options for Complex Coronary Lesions

Four Intravascular Imaging Studies Shared the ESC Spotlight, Yet Shadows Persist

No Downside to Immediate Complete Revascularization in ACS: BIOVASC

Stable CAD Plaque Morphology Improved by PCSK9 Inhibitors: YELLOW III

Cardiac Imaging’s Carbon Footprint: Time for Awareness and Action

July 2022 News Roundup

January 2022 News Roundup

IVUS-Guided PCI Tied to Better Long-term Outcomes After Acute MI

Primary PCI Underused but Just as Effective in Cancer Patients With STEMI

New Expert Advice on Intracoronary Imaging Urges Shift to Preprocedural Planning

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

Twitter Takes on the Times of India, but the Question Persists: Is Foregoing a Stent an Option?

High Rate of Residual Ischemia After PCI Despite Excellent Angiographic Outcomes: DEFINE-PCI

ABSORB II Substudy Digs Into Long-term Arterial Remodeling Following BRS, DES Implantation

PCSK9 Inhibition and Other New Therapies for Lipid Modification: Good News and Bad

MILANO-PILOT Falters, Effectively Ending the ApoA-1 Milano Saga

‘Worrisome’ 3-Year Data From ABSORB II Raise Concerns About First-Generation Bioresorbable Stent

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content